Blogs

Drug Pricing Executive Order: Likely Win for Pharma

Fran Quigley Despite President Trump’s repeated promises to take on the pharmaceutical industry and drug pricing, his recently released Executive Order shows he will do no such thing. In fact, Trump hired industry executives to lead the process of…

WHO Budget Commitments Disappoint Global Health Advocates

WHO Watchers in Geneva Fran Quigley, in Geneva The election of Dr. Tedros Adhanom Ghebreyesus as the new director-general of the World Health Organization has dominated the news from the 70th World Health Assembly. But, arguably, it was not the…

Dr Tedros Promises WHO Reform with Human Rights at the Core

Dr. Tedros Adhanom Ghebreyesus has been elected Director-General of the World Health Organization (WHO) for the next five years. Dr Tedros, Ethiopia’s foreign minister and former health minister, believes WHO must evolve and adapt to urgent global health…

Listen to Civil Society: Medicines for People, Not Profit—Dr Chan

Fran Quigley, from the WHA in Geneva In her final address to the World Health Assembly as WHO Director-General, Dr. Margaret Chan identified access to medicines as the most contentious issue of her decade-long tenure. That struggle was engaged, she…

Remove the For-Profit Variable from Clinical Drug Trials

Fran Quigley At first glance, it seems that clinical trials are the much-criticized pharmaceutical industry’s best contribution to the medicines process. The industry leans on governments to fund early-stage research, then claims the patent rights to…